Response to the FDA Dosage Optimization Draft Guidance for Radiopharmaceutical Therapies.

Kiess AP, Sunderland JJ, Scott PJH, Hope TA

Open source

DOI
10.2967/jnumed.126.272138
Published
2026 Sep 2
Container
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.126.272138,
  title = {Response to the FDA Dosage Optimization Draft Guidance for Radiopharmaceutical Therapies.},
  author = {Kiess AP and Sunderland JJ and Scott PJH and Hope TA},
  year = {2026},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.126.272138},
  url = {https://doi.org/10.2967/jnumed.126.272138}
}

RIS

TY  - JOUR
TI  - Response to the FDA Dosage Optimization Draft Guidance for Radiopharmaceutical Therapies.
AU  - Kiess AP
AU  - Sunderland JJ
AU  - Scott PJH
AU  - Hope TA
PY  - 2026
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.126.272138
UR  - https://doi.org/10.2967/jnumed.126.272138
ER  - 

APA

AP, K., JJ, S., PJH, S., & TA, H. (2026). Response to the FDA Dosage Optimization Draft Guidance for Radiopharmaceutical Therapies.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272138

Source records